You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

metastatic cutaneous melanoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan, Interleukin-2)

Not yet recruiting
  • Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Jun 5, 2023

Melanoma (Skin), Cutaneous Melanoma, Adult Disease Trial in France, Spain, United States (ANV419, Pembrolizumab, Ipilimumab)

Recruiting
  • Melanoma (Skin)
  • +4 more
  • Bloomington, Minnesota
  • +7 more
Jan 31, 2023

Unresectable Cutaneous Melanoma, Metastatic Cutaneous Melanoma Trial in Worldwide (Sintilimab + IBI110)

Withdrawn
  • Unresectable Cutaneous Melanoma
  • Metastatic Cutaneous Melanoma
  • Sintilimab + IBI110
  • San Francisco, California
  • +12 more
Nov 16, 2022

Metastatic Uveal Melanoma, Metastatic Cutaneous Melanoma Trial (Autologous Tumor Infiltrating Lymphocytes, Melphalan,

Not yet recruiting
  • Metastatic Uveal Melanoma
  • Metastatic Cutaneous Melanoma
  • Autologous Tumor Infiltrating Lymphocytes
  • +2 more
  • (no location specified)
Oct 14, 2022

Metastatic Melanoma Trial in Burnsville (Aldesleukin: All Patients, Nivolumab: Cohort 1 (Cutaneous), Nivolumab: Cohort 2

Active, not recruiting
  • Metastatic Melanoma
  • Aldesleukin: All Patients
  • +3 more
  • Burnsville, Minnesota
    University of Minnesota Masonic Cancer Center
Feb 25, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +20 more
  • Neoantigen Peptide Vaccine
  • +2 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Sep 7, 2022

Metastatic Melanoma, Recurrent Cutaneous Melanoma, Stage IV Cutaneous Melanoma AJCC v6 and v7 Trial in United States (Ibrutinib,

Active, not recruiting
Has Results
  • Metastatic Melanoma
  • +2 more
  • Los Angeles, California
  • +12 more
Jul 27, 2022

Melanoma Trial (ONCOS-102, Balstilimab)

Not yet recruiting
  • Melanoma
  • ONCOS-102
  • Balstilimab
  • (no location specified)
Oct 24, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma Trial in

Not yet recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +4 more
  • Nashville, Tennessee
    Vanderbilt University/Ingram Cancer Center
Feb 28, 2023

Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7 Trial in Rochester (drug,

Active, not recruiting
  • Metastatic Melanoma
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 13, 2023

Monitoring T Cell Responses in Melanoma, Lung and Other Cancer

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +9 more
  • Biospecimen Collection
  • Electronic Health Record Review
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Oct 4, 2023

Clinical Stage III Cutaneous Melanoma AJCC v8, Stage IV Melanoma, Unresectable Stage III Cutaneous Melanoma Trial in Boston

Recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +3 more
  • Boston, Massachusetts
  • +2 more
Sep 17, 2022

Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7, Stage IIIC Cutaneous Melanoma AJCC v7 Trial in Jacksonville (drug,

Active, not recruiting
  • Metastatic Melanoma
  • +3 more
  • Jacksonville, Florida
    Mayo Clinic in Florida
Jan 3, 2023

Melanoma (Skin) Trial in Dijon, Thionville, Vandœuvre-lès-Nancy (Blood sampling)

Active, not recruiting
  • Melanoma (Skin)
  • Blood sampling
  • Dijon, France
  • +3 more
Mar 29, 2022

Metastatic Malignant Tumor in the Brain, Metastatic Melanoma, Stage III Cutaneous Melanoma AJCC v7 Trial in Houston (drug,

Active, not recruiting
  • Metastatic Malignant Neoplasm in the Brain
  • +7 more
  • Houston, Texas
    M D Anderson Cancer Center
Jun 15, 2022

Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

Active, not recruiting
  • Stage III Cutaneous Melanoma AJCC v7
  • +4 more
  • Cryosurgery
  • +3 more
  • Rochester, Minnesota
    Mayo Clinic
Jan 3, 2023

Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in

Completed
Has Results
  • Stage III Cutaneous Melanoma AJCC v7
  • +5 more
  • Aldesleukin
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Oct 17, 2022

Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)

Recruiting
  • Metastatic Melanoma
  • +9 more
  • TBio-4101
  • +3 more
  • Tampa, Florida
    Moffitt Cancer Center
Jan 24, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Los Angeles

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Magnetic Resonance Imaging using 7 Tesla MRI
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 12, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IV Cutaneous Melanoma AJCC v8 Trial in

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Aug 9, 2022

Cancer, Melanoma Stage III, Melanoma Stage IV Trial (KB707)

Not yet recruiting
  • Cancer
  • +6 more
  • KB707
  • (no location specified)
Jul 24, 2023

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Columbus

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 28, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

Active, not recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +20 more
  • Ipilimumab
  • +3 more
  • Tampa, Florida
  • +6 more
Jan 13, 2023

BRAF V600E Mutation Present, BRAF V600K Mutation Present, Metastatic Malignant Solid Tumor Trial in Boston (Dabrafenib,

Active, not recruiting
  • BRAF V600E Mutation Present
  • +9 more
  • Boston, Massachusetts
  • +1 more
Jun 28, 2022

Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Cutaneous

Not yet recruiting
  • Clinical Stage III Cutaneous Melanoma AJCC v8
  • +12 more
  • Biopsy
  • +8 more
  • (no location specified)
Jun 8, 2023